Skip to main content
. 2025 Jan 1;20(1):1–12. doi: 10.2185/jrm.2024-025

Table 1. Basic information of the patients.

Total (n=50) Male (n=19) Female (n=31) P-value
Age (years) 78.8 (6.3) 81.0 [77.0–84.0] 78.1 (6.1) 0.190a
Living together 46 (87.3%) 19 (100%) 27 (87.1%) 0.284b
Osteoarthritis (yes) 11 (22.0%) 3 (15.8%) 8 (25.8%) 0.498b
Neurological disease (yes) 0 (0%) 0 (0%) 0 (0%)
Heart disease (yes) 5 (10.0%) 1 (5.3%) 4 (12.9%) 0.637b
Respiratory disease (yes) 4/46 (8.0%) 3 (15.8%) 1 (3.3%) 0.147b
Hypertension (yes) 22 (44.0%) 6 (31.6%) 16 (51.6%) 0.242b
Diabetes (yes) 9 (18.0%) 4 (21.1%) 5 (16.1%) 0.715b
Height (cm) 156.4 (6.3) 164.4 (7.9) 151.6 (7.0) <0.01c
Weight (kg) 57.0 (9.0) 59.2 (6.6) 55.7 (10.1) 0.137c
BMI 23.3 (3.6) 22.0 (2.8) 24.2 (3.7) 0.034c
Body fat rate (%) 28.4 (8.9) 21.6 (7.6) 32.6 (6.8) <0.01c
ASMI 6.5 (0.90) 7.1 (0.62) 6.2 (0.76) <0.01c
Max. grip strength (kgf) 25.7 (7.7) 31.5 (9.1) 22.2 (3.8) <0.01c
SPPB Balance test 4.0 [4.0–4.0] 4.0 [4.0–4.0] 4.0 [4.0–4.0] 0.959a
SPPB Gait speed test 4.0 [4.0–4.0] 4.0 [4.0–4.0] 4.0 [4.0–4.0] 0.519a
SPPB Chair stand test 4.0 [4.0–4.0] 4.0 [4.0–4.0] 4.0 [4.0–4.0] 0.071a
SPPB Total score 12.0 [12.0–12.0] 12.0 [12.0–12.0] 12.0 [11.0–12.0] 0.331a
Walking speed (m/sec) 1.15 (0.21) 1.20 (0.23) 1.13 (0.20) 0.233c
FTSST (sec) 9.1 [7.7–9.9] 8.6 [7.8–9.8] 9.3 [7.4–10.4] 0.896a
Low muscle mass 14 (28.0%) 8 (42.1%) 6 (19.4%) 0.110b
Weakened muscle 16 (32.0%) 9 (47.4%) 7 (22.6%) 0.117b
Sarcopenia 9 (18.0%) 4 (21.1%) 5 (16.1%) 0.715b

a: Mann–Whitney’s U-test, b: chi-square test or Fisher’s exact test, c: unpaired t-test.

BMI: body mass index: ASMI; appendicular skeletal muscle mass index; SPPB: short physical performance battery; FTSST: five-times-sit-to-stand test.